Talk (33)

51.
Talk
Wenzel, L.; Ruhnau, J.; Rexer, T.; Reichl, U.: Chemoenzymatic glycosylation of polypeptides using eukaryotic oligosaccharyltransferase and synthetic lipid-linked glycans. Glyco26, Taipei (Taiwan) (2023)
52.
Talk
Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus production. 4th Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, Dublin (Ireland) (2023)
53.
Talk
Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: A quest for the best influenza producing clonal MDCK cell line: intensifying by design of experiments, ambr15 and bench-top bioreactor cultivations. World Biopharm Forum 2023 - Democratisation of biotherapies: new manufacturing modalities and intensifications, Oxford (United Kingdom) (2023)
54.
Talk
Zuniga-Banuelos, F. J.; Hoffmann, M.; Budimir, I.; Reichl, U.; Rapp, E.: New avenues for biomarker discovery in human blood plasma via an improved in-depth analysis of the low-abundant N-glycoproteome. GlycoBioTec 2023, Berlin, Germany (2023)

Poster (20)

55.
Poster
Alcalá Orozco, E. A.; Fiebig, T.; Mahour, R.; Grote, V.; Rexer, T.; Reichl, U.: Development of a cell-free multi-enzyme cascade for the synthesis of CDP-glycerol. GlycoBioTec 2023, Berlin, Germany (2023)
56.
Poster
Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)
57.
Poster
Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
58.
Poster
Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Baelkner, M.; Julia D. Boehme, J. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 8th European Congress of Virology, Gdańsk (Poland) (2023)
59.
Poster
Hoang Son, T.; Lange, F.; Rexer, T.; Reichl, U.: Multi-gram-scale production of uridine nucleotide sugars by in-vitro multi-enzyme cascades. GlycoBioTec 2023, Berlin, Germany (2023)
60.
Poster
Hoang Son, T.; Wormstall, S.-T.; Rexer, T.; Reichl, U.: Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approach. GlycoBioTec 2023, Berlin, Germany (2023)
61.
Poster
Juárez-Osorio, M.; Darr, A.; Volckmar, J.; Bruder, D.; Rexer, T.; Reichl, U.: Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein. GlycoBioTec 2023, Berlin, Germany (2023)
62.
Poster
Küchler, J.; Opitz, P.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of viral proteins during single-round replication of vaccine producer cell lines. 32nd Annual Meeting of the Society for Virology (GfV) , Ulm (Germany) (2023)
63.
Poster
Küchler, J.; Opitz, P.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell lines. 16th PEACe (Protein Expression in Animal Cells) Conference, Sitges (Spain) (2023)
64.
Poster
Lemke, G.; Zuniga-Banuelos, F. J.; Grote, V.; Hoffmann, M.; Rapp, E.; Reichl, U.: N-glycan Sulfation on Human IgA: In-Depth N-glycoproteomic Analyses of Sulfated N-glycan Site-Specificity and Distribution on Human IgA Isotypes. GlycoBioTec 2023, Berlin, Germany (2023)
65.
Poster
Pelz, L.; Dogra, T.; Boehme, J.D.; Hein, M. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)
66.
Poster
Pelz, L.; Dogra, T.; Boehme, J.D.; Marichal-Gallardo, P.; Hein, M. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo Studies. Himmelfahrtstagung on Bioprocess Engineering 2023, Weimar (Germany) (2023)
67.
Poster
Pelz, L.; Dogra, T.; Boehme, J.D.; Marichal-Gallardo, P.; Hein, M. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral Efficacy. 32nd Annual Meeting of the Society for Virology (GFV), Ulm (Germany) (2023)
68.
Poster
Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8th European Congress of Virology, Gdańsk (Poland) (2023)
69.
Poster
Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
70.
Poster
Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17th Vaccine Congress, Glasgow (Scotland) (2023)
71.
Poster
Rexer, T.; Alcalá Orozco, E. A.; Hoang Son, T.; Kleeberg, S.; Reichl, U.: Platform for the scalable synthesis of human milk oligosaccharides. The Origins and Benefits of Biologically Active Components in Human Milk Conference, Florida, USA (2023)
72.
Poster
Sultan Mohideen, M. A. H.; Khesali Aghtaei, H.; Reichl, U.; Benndorf, D.: Development of a packed foam bed bioreactor for biological methanation. 6th International Conference on Monitoring and Control of Anaerobic Digestion Processes, Leipzig, Germany (2023)
73.
Poster
Wenzel, L.; Ruhnau, J.; Hoffmann, M.; Rexer, T.; Reichl, U.: Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)
74.
Poster
Zuniga-Banuelos, F. J.; Hoffmann, M.; Budimir, I.; Reichl, U.; Rapp, E.: New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-Glycoproteome. GlycoBioTec 2023, Berlin, Germany (2023)

Thesis - PhD (1)

75.
Thesis - PhD
Pralow, A.: Method development and its application for N-glycan analysis of influenza A virus antigens. Dissertation, Otto-von-Guericke-Universität Magdeburg, Magdeburg (2023)

Thesis - Master (9)

76.
Thesis - Master
Shih, Y.-T.: The expression of different alpha-L-fucosidases in Escherichia coli and the evaluation of its defucosylation activity on isolated N-glycans and glycoproteins. Master, Technische Universität, München (2023)
77.
Thesis - Master
Hassler, J.: Establishment of an enzyme cascade for in-vitro glycomodification of high-mannose-type glycoproteins. Master, Otto-von-Guericke-Universität, Magdeburg (2023)
78.
Thesis - Master
Kautzner, D.: Identifizierung neu synthetisierter Proteine in mikrobiellen Gemeinschaften: Entwicklung einer selektiven Anreicherungsmethode mit BONCAT und Click-Chemie. Master, Otto-von-Guericke-Universität, Magdeburg (2023)
79.
Thesis - Master
Wormstall, S.-T.: Optimierung der Prozessparameter einer Multienzymkaskade zur Synthese des Nukleotidzuckers Uridindiphosphat N-Acetylgalactosamin. Master, Otto-von-Guericke-Universität Magdeburg, Magdeburg (2023)
80.
Thesis - Master
Müller, P. F.: Recombinant Expression of Glycosyltransferases for in vitro Glycoengineering of LL-Man3. Master, Hochschule Furtwangen University, Furtwangen (2023)
81.
Thesis - Master
Pardo Cacho, J.: Process development for the biocatalytic synthesis of CMP-Neu5Ac. Master, Otto-von-Guericke-Universität, Magdeburg (2023)
82.
Thesis - Master
Opitz, P.: Analysis and quantification of influenza virus protein production in different cell lines. Master, Universität, Konstanz (2023)
83.
Thesis - Master
Lange, F.: Multi-Gram-scale production of uridine nucleotide sugars via in-vitro multi-enzyme cascades. Master, Faculty for Biotechnology, University of applied sciences Mannheim, Mannheim, Germany (2023)
84.
Thesis - Master
Sultan Mohideen, M.A.H.: Development of a packed foam bed bioreactor for biological methanation. Master, Otto-von-Guericke-Universität Magdeburg, Magdeburg (2023)

Thesis - Bachelor (3)

85.
Thesis - Bachelor
Thomas, L.: Prozessetablierung zur Synthese kurzkettiger und linearer Humaner Milch Oligosaccharide mittels rekombinanter Enzyme. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2023)
86.
Thesis - Bachelor
Wicke, E.: Influenza A Virusproduktion in monoklonalen MDCK-Suspensionszelllinien in Hochzelldichte. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2023)
87.
Thesis - Bachelor
Rössig, M.-L.: Stability analysis of a chimeric yellow fever-Zika vaccine construct. Bachelor, Otto-von-Guericke-Universität, Magdeburg (2023)
Go to Editor View